- +494.4% price growth over the last year
- Strong return on equity of 56.4%
- Lower volatility than the market (beta 0.13)
CURE Pharmaceutical Holding Corp. stock downgraded to Sell Candidate
(Updated on Jun 09, 2026)
The CURE Pharmaceutical Holding Corp. stock price fell by -0.337% on the last day (Tuesday, 9th Jun 2026) from $2.97 to $2.96. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.22% from a day low at $2.91 to a day high of $3.12. The price has fallen in 6 of the last 10 days and is down by -9.48% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -91 thousand shares and in total, 176 thousand shares were bought and sold for approximately $520.03 thousand.
Given the current short-term trend, the stock is expected to rise 30.93% during the next 3 months and, with a 90% probability hold a price between $3.88 and $6.36 at the end of this 3-month period.
CURR Signals & Forecast
There are few to no technical positive signals at the moment. The CURE Pharmaceutical Holding Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.17 and $3.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 11, 2026, and so far it has fallen -34.08%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for CURE Pharmaceutical Holding Corp. stock
CURE Pharmaceutical Holding Corp. finds support from accumulated volume at $2.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.210 between high and low, or 7.22%. For the last week the stock has had daily average volatility of 13.50%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CURR) For The Upcoming Trading Day Of Wednesday 10th
For the upcoming trading day on Wednesday, 10th we expect CURE Pharmaceutical Holding Corp. to open at $3.00, and during the day (based on 14 day Average True Range), to move between $2.80 and $3.12, which gives a possible trading interval of +/-$0.327 (+/-11.68%) up or down from last closing price. If CURE Pharmaceutical Holding Corp. takes out the full calculated possible swing range there will be an estimated 11.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.87 (3.04%) than the resistance at $3.21 (8.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is CURE Pharmaceutical Holding Corp. stock A Buy?
The CURE Pharmaceutical Holding Corp. stock holds several negative signals and despite the positive trend, we believe CURE Pharmaceutical Holding Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-1.490
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 10, 2026 - $3.00 ( 1.24%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CURR Performance
Trading levels for CURR
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.21 | 8.33% |
| R2 | 3.13 | 5.62% |
| R1 | 3.08 | 3.95% |
| Price | 2.96 | |
| S1 | 2.92 | -1.47% |
| S2 | 2.87 | -3.15% |
| S3 | 2.79 | -5.86% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.55 | 19.93% |
| R2 | 3.48 | 17.57% |
| R1 | 3.21 | 8.45% |
| Price | 2.96 | |
| S1 | 2.87 | -3.04% |
| S2 | 2.69 | -9.12% |
| S3 | 2.62 | -11.49% |
FAQ
Click here for our free guide on how to buy CURE Pharmaceutical Holding Corp. Stock.
Buy CURR